128 related articles for article (PubMed ID: 15036553)
21. Satisfaction with methadone as a medication: psychometric properties of the Spanish version of the treatment satisfaction questionnaire for medication.
Trujols J; Iraurgi I; Siñol N; Portella MJ; Pérez V; Pérez de Los Cobos J
J Clin Psychopharmacol; 2012 Feb; 32(1):69-74. PubMed ID: 22198457
[TBL] [Abstract][Full Text] [Related]
22. [General practitioner views on drug-assisted rehabilitation and the Norwegian substance abuse reform].
Aasland OG; Spilhaug G; Johannesen A
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):97-100. PubMed ID: 19151800
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
24. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
25. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
[TBL] [Abstract][Full Text] [Related]
26. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
[TBL] [Abstract][Full Text] [Related]
27. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
Bell J; Mutch C
Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307
[TBL] [Abstract][Full Text] [Related]
28. Methadone medical maintenance in primary care. An implementation evaluation.
Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
[TBL] [Abstract][Full Text] [Related]
29. Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients.
Sigmon SC; Stitzer ML
J Subst Abuse Treat; 2005 Dec; 29(4):253-8. PubMed ID: 16311177
[TBL] [Abstract][Full Text] [Related]
30. Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff.
Gjersing LR; Butler T; Caplehorn JR; Belcher JM; Matthews R
Drug Alcohol Rev; 2007 Sep; 26(5):501-8. PubMed ID: 17701513
[TBL] [Abstract][Full Text] [Related]
31. Client satisfaction with substance abuse treatment.
Rohrer JE; Hilsenrath P
Health Mark Q; 1999; 17(2):31-42. PubMed ID: 11010209
[TBL] [Abstract][Full Text] [Related]
32. Relationship between perceived improvement and treatment satisfaction among clients of a methadone maintenance program.
Perreault M; White ND; Fabrès E; Landry M; Anestin AS; Rabouin D
Eval Program Plann; 2010 Nov; 33(4):410-7. PubMed ID: 20089307
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
[TBL] [Abstract][Full Text] [Related]
34. User views on supervised methadone consumption.
Stone E; Fletcher K
Addict Biol; 2003 Mar; 8(1):45-8. PubMed ID: 12745415
[TBL] [Abstract][Full Text] [Related]
35. [Buprenorphine and methadone to opiate addicts--a randomized trial].
Kristensen Ø; Espegren O; Asland R; Jakobsen E; Lie Ø; Seiler S
Tidsskr Nor Laegeforen; 2005 Jan; 125(2):148-51. PubMed ID: 15665884
[TBL] [Abstract][Full Text] [Related]
36. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
[TBL] [Abstract][Full Text] [Related]
37. Quality of life among heroin users on buprenorphine versus methadone maintenance.
Ponizovsky AM; Grinshpoon A
Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
[TBL] [Abstract][Full Text] [Related]
38. Physicians practicing in methadone treatment programs: who are they and what do they do?
Wechsberg WM; Flannery B; Kasten JJ; Suerken C; Dunlap L; Roussel AE; Crum L; Murdoch O; Diesenhaus H
J Addict Dis; 2004; 23(2):15-31. PubMed ID: 15132340
[TBL] [Abstract][Full Text] [Related]
39. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
40. [Comment to a contribution on methadone program in Stockholm].
Eriksson N
Lakartidningen; 2001 Dec; 98(50):5797. PubMed ID: 11789109
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
